Otilimab (Anti-CSF2 / GM-CSF)

Synonyms: GSK 3196165; MOR103

Otilimab (GSK 3196165) is an humanized monoclonal antibody targeting GM-CSF (granulocyte-macrophage colony-stimulating factor). Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor. MW: 145.5 KD.

Otilimab (Anti-CSF2 / GM-CSF)

Purity & Quality Control

Batch: A253301 Purity: 99% Protein concentration: 9.35mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Otilimab (GSK 3196165) is an humanized monoclonal antibody targeting GM-CSF (granulocyte-macrophage colony-stimulating factor). Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor. MW: 145.5 KD.

Product Details

CAS No. 1638332-55-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Otilimab (Anti-CSF2 / GM-CSF) | Otilimab (Anti-CSF2 / GM-CSF) supplier | purchase Otilimab (Anti-CSF2 / GM-CSF) | Otilimab (Anti-CSF2 / GM-CSF) cost | Otilimab (Anti-CSF2 / GM-CSF) manufacturer | order Otilimab (Anti-CSF2 / GM-CSF) | Otilimab (Anti-CSF2 / GM-CSF) distributor